Recombinant Human DCBLD2/ESDN Protein (aa 67-528, His Tag) | PKSH032343

(No reviews yet) Write a Review
SKU:
575-PKSH032343
€535.00
Frequently bought together:

Description

Recombinant Human DCBLD2/ESDN Protein (aa 67-528, His Tag) | PKSH032343 | Gentaur US, UK & Europe Disrtribition

Synonyms: Discoidin; CUB and LCCL domain-containing protein 2;DCBLD2;CUB; LCCL and coagulation factor V/VIII-homology domains protein 1;Endothelial and smooth muscle cell-derived neuropilin-like protein;DCBLD2;CLCP1; ESDN

Active Protein: N/A

Activity: Recombinant Human Discoidin, CUB and LCCL domain-containing protein 2 is produced by our Mammalian expression system and the target gene encoding Gln67-Ala528 is expressed with a 6His tag at the C-terminus.

Protein Construction: Recombinant Human Discoidin, CUB and LCCL domain-containing protein 2 is produced by our Mammalian expression system and the target gene encoding Gln67-Ala528 is expressed with a 6His tag at the C-terminus.

Fusion Tag: C-6His

Species: Human

Expressed Host: Human Cells

Shipping: This product is provided as lyophilized powder which is shipped with ice packs.

Purity: > 95 % as determined by reducing SDS-PAGE.

Endotoxin: < 1.0 EU per µg as determined by the LAL method.

Stability and Storage: Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.

Molecular Mass: 52.2 kDa

Formulation: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.

Reconstitution: Please refer to the printed manual for detailed information.

Background: Discoidin, CUB and LCCL domain-containing protein 2(DCBLD2) is a protein contains 1 CUB domain, 1 F5/8 type C domain, 1 LCCL domain. DCBLD2 is Highly expressed in testis, heart, skeletal muscle and also in cultured vascular smooth muscle cells. Model organisms have been used in the study of DCBLD2 function. Male and female animals underwent a standardized phenotypic screen to determine the effects of deletion. Additional screens performed: In-depth immunological phenotyping.

Research Area: Cardiovascular, Cancer

View AllClose